Ulinastatin
6 clinical trials
1 abstract
9 indications
Indication
Acute Aortic SyndromeIndication
Aortic DissectionIndication
Pharmacological ActionIndication
SepsisIndication
Septic shockIndication
MODSIndication
Oral Mucositis Due to RadiationIndication
Non-depolarizing muscle relaxantsIndication
Cardiac ComplicationClinical trial
Effects of Ulinastatin on Inflammatory Response for Acute Aortic Syndrome PatientsStatus: Completed, Estimated PCD: 2022-06-30
Abstract
The efficacy and safety of ulinastatin in the prevention and treatment of radiotherapy-induced oral mucositis in locoregionally advanced nasopharyngeal carcinoma (LA-NPC): A multicenter, open-label, randomized controlled clinical trial.Org: Department of Comprehensive (Head and Neck) Oncology and Hospice Ward, The People's Hospital of Zhongshan City, Department of Radiation Oncology, The Third Affiliated Hospital of Sun Yat-sen University, The Eastern Hospital of the First Affiliated Hospital, Sun Yat-sen University, The State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Center for Precision Medicine, Sun Yat-sen University,
Clinical trial
Ulinastatin Improves and Prevents Cardiac Dysfunction Induced by Cardiopulmonary Bypass by Reducing Cardiac Endothelial PermeabilityStatus: Recruiting, Estimated PCD: 2024-12-30
Clinical trial
MUNI-SEP TRIAL-The Role of Ulinastatin in Preventing Severe Sepsis and Consequent Morbidities and Mortality; A Randomized Clinical Trial in Pakistan.Status: Recruiting, Estimated PCD: 2023-10-01
Clinical trial
A Phase 3, Open Label, Multicenter, Randomized Controlled Clinical Trial to Evaluate the Efficacy of Ulinastatin in the Reduction of Acute Oral Mucositis Caused by Concurrent Chemoradiotherapy(CCRT) for Patients With Localregionally Advanced Nasopharyngeal Carcinoma (NPC).Status: Active (not recruiting), Estimated PCD: 2021-12-28
Clinical trial
Effect of Ulinastatin on the Action of Nondepolarising Muscle Relaxants Rocuronium / CisatracuriumStatus: Not yet recruiting, Estimated PCD: 2023-06-15
Clinical trial
Ulinastatin Improves Post-Cardiac Surgery Cognitive Dysfunction by Inhibiting Glycocalyx Degradation: An Observational StudyStatus: Completed, Estimated PCD: 2022-12-30